An infective preparation of extracellular blood forms (FP) of Plasmodium berghei was used to study some aspects of the interaction between protective antibodies and malaria parasites. FP but not infected erythrocytes (IRBC) were shown by the fluorescent antibody technique to be coated by antibodies after in vitro incubation with immune serum. Preincubation of both FP and IRBC with immune serum followed by their washing did not result in enhanced elimination of the parasites in vivo. However, FP preincubated with immune serum and subsequently washed were eliminated more efficiently than FP preincubated with normal serum if the preparations were injected with some immune serum. Such an increase in the efficiency of elimination was not detected with similarly pretreated IRBC. It is thus probable that protective antibodies acted in vivo against extracellular parasites rather than against parasites in erythrocytes. The interaction between parasites and antibodies may be of a highly reversible nature, and washing of the in vitro-treated parasites may cause elution of antibody from the sensitized parasites so that the amount of antibody on the parasite falls below the critical level required for in vivo elimination.
The ability of antibodies to protect various animals including humans against malaria parasites has been repeatedly demonstrated by passive transfer experiments (1, 8, 10, 13, 18, 26) As in all of these studies, protective antibody activity was determined against a preexisting infection or against an inoculum of infected erythrocytes (IRBC), and it was impossible to determine whether IRBC or extracellular parasites were the target of the protective antibodies. That protective antibodies may exert their activity on free malaria parasites (FP) rather than on IRBC was suggested by Cohen et al. (10) , on the basis of the observation that after hyperimmune serum was transferred from adult Gambians to children infected with Plasmodium falciparum a substantial drop in numbers of circulating parasites did not occur until after the parasites had undergone schizogony. An experimental evaluation of the hypothesis that antibody acts more efficiently against FP than against IRBC was recently made by Cohen and Butcher (9) . These (as measured by uptake of [8H]leucine) but did completely arrest development after schizogony. These authors suggested that the inhibitory antibody acts on merozoites as antiviral neutralizing antibodies act on viruses and that the antibody interferes with merozoite penetration into erythrocytes. A more recent study by Miller et al. (17) has shown that addition of hyperimmune serum to cultures of P. knowlesi schizonts causes aggregation of the emerging merozoites and that although attachment of the parasites to erythrocytes may be achieved, penetration is not completed. These authors suggested that the interaction of antibody with merozoites will not prevent penetration unless the merozoites are agglutinated. The in vivo situation in this respect is less clearly understood Harvesting of FP. FP were harvested from the blood of infected mature rats after parasitemia reached about 50%. To obtain such a high parasitemia in rats, it was necessary to pretreat them with phenylhydrazine in order to increase their reticulocyte counts and thus make them more susceptible to P. berghei infection. To do this, the rats were given two injections of 30 mg of phenylhydrazine per kg of body weight. The injections were given 48 h apart, and 48 h later the rats were infected by the intravenous injection of heavily infected mouse blood. Parasitemia reached 50% 3 to 4 days later. FP were isolated from the infected blood by a modified continuous-flow sonication procedure (19, 20 or 30 min in a water bath at 37 C or at room temperature for 5 min. After three repeated washes with 3-ml volumes of Alsever solution, the parasites were resuspended to a volume of 0.1 ml and incubated for 30 min at 37 C with 0.05 ml of fluorescent anti-rat gamma globulin (diluted 1:2 in Alsever solution). This step was followed by three washes in Alsever solution and resuspension to a volume of 0.1 ml. A drop of each sample was examined under the fluorescence microscope.
RESULTS
A preliminary study was done by the fluorescent antibody technique on fresh unfixed cells to determine whether antiplasmodial antibodies bind to FP and/or IRBC (Table 1) . FP pretreated with serum from recovered rats and washed extensively thereafter were strongly stained by fluorescent rabbit immunoglobulin G raised against rat gamma globulin, whereas infected and normal erythrocytes were not. FP in the preparation of IRBC were also stained. These results indicate that parasites were protected from antibody activity when within erythrocytes. However, once free from the protective envelope of the erythrocyte, the parasites became coated with antibody, even if they were separated from the antibody by washing after as short an interval as 5 min. Some fluorescence was also detected on FP treated with normal rat serum, which indicates that some In the experiments described so far, we used immune serum that was raised by infecting rats with P. berghei and reinoculating them after their recovery from infection. To find out whether reinoculation might have affected the binding character of the antibody, we harvested serum from rats 6 weeks after their recovery from P. berghei infection, without reinoculation, and used it in an experiment similar to that described in Table 4 . The results of the experiment with serum from recovered animals are presented in Table 7 . The protective activity of this serum was relatively weak since even undiluted serum allowed parasites to cause like IRBC subjected to similar pretreatment and washing conditions (Table 3) . These observations with pretreated FP and IRBC confirm previous observations (6, 14, 16 (9) , which was based on the observation that antibodies inhibit the in vitro development of P. knowlesi at stages following schizogony. They may also indicate that a critical amount of protective antibodies must be maintained in association with the parasites in order to allow their efficient elimination and that washing of the free parasites after their incubation with protective antiserum leaves only a subcritical amount of protective antibodies on the surface of the parasites. It still remains possible that a substantial proportion of antibodies that coat FP are not protective.
The relative ease by which protective antibodies seem to be removed by washing (Table 2) and the apparent requirement for continuous presence of unbound antibodies (Table 4) suggest that the association of protective antibodies with the parasites is of a highly reversible nature. This may be attributed to low avidity of the protective antibodies or to shedding of antigen-antibody complexes from the parasite's surface. The possibility that protective antibodies do not affect the parasites irreversibly and that protective antibody activity depends on additional conditions in the host emerges from the finding that similar immune sera had different protective activity in different animals, ranging from no apparent protection in mice to various degrees of protection in two different strains of rats (Hamburger and Kreier, unpublished data). Also, since complement activity does not appear to be required for protective antibody activity in vitro (9) and in vivo (15) , it seems unlikely that activation of complement by parasite-antibody complexes leads to killing of parasites, nor is it likely that phagocytosis of parasites by macrophages is substantially enhanced by complement.
In relating to the possibility that the protective antibodies may have low avidity, it should be mentioned that the bulk of the protective activity against P. berghei lies in the immunoglobulin G fraction, whereas multivalent antibody moleucles, which may increase the overall avidity of protective sera, do not seem to play a major role in protection (13, 18 The ability of the merozoite to invade an erythrocyte relative to the efficiency of the reticuloendothelial system in ingesting the merozoites probably determines the fate of the malaria parasite, since the presence of circulating merozoites can be considered an event of short duration, culminating either in successful penetration or in elimination by phagocytes. It is known that manipulations that decrease total reticuloendothelial system activity, such as splenectomy, and those that increase the number of reticulocytes will also increase the susceptibility of rodents to P. berghei infection (25) . In a situation where phagocytes, on the one hand, and erythrocytes, on the other, may compete with each other in taking up FP, it is not imperative that protective antibodies irreversibly neutralize the parasites in order to affect their elimination, since even an unstable state of neutralization may delay penetration and thus increase the chances for elimination. It has been proposed by Cohen and Butcher (9) that antibodies which inhibit in vitro development of P. knowlesi neutralize merozoites as antiviral antibodies neutralize viruses. Miller et al. (17) , on the other hand, proposed that protective antibodies act as agglutinins and that agglutinated merozoites are incapable of penetration. A highly dissociable protective antibody may indeed be analogous to some virus-neutralizing antibody systems (11). It is not inconceivable, however, that both neutralization and agglutination of parasites by delaying penetration into erythrocytes may contribute in some degree to the elimination of the parasites by the phagocytes.
Antibody-mediated antigenic variation of malaria parasites has been described in rodent (2, 12) , monkey (3, 5, 23) , and human malaria (22) and is considered a major mechanism by INFECTr. IMMUN .
on November 2, 2017 by guest http://iai.asm.org/ Downloaded from which malaria parasites survive in an immunologically hostile environment (4). Furthermore, it has been shown that antibodies which inhibit the in vitro growth of P. knowlesi are predominantly variant specific (7) . In view of our findings, it appears possible that an easily reversible parasite-protective antibody interaction may also contribute to the ability of malaria parasites to evade the immune response.
Our results showed that a "weak" antiserum harvested after recovery and without reinoculation had a lesser capacity to remain associated with the parasites after pretreatment and washing than a serum produced by reinfection (Table 7 ). It appears possible, therefore, that repeated hyperimmunizations with plasmodia may induce antibodies of progressively higher affinity. Butcher and Cohen (7) have recently demonstrated that repeated reinfections of monkeys with the same variant of P. knowlesi induces the production of inhibitory antibodies against other variants. They postulated that this nonhomologous protection might be attributed to low-affinity cross-reacting antibodies or to antibodies produced by repeated immunization to common antigenic determinants present in small amounts in the parasites. The reversible nature of antibody-parasite interaction suggests that antibodies of low affinity may be involved in this type of nonhomologous protection.
The model used in our study provides a convenient and relatively inexpensive tool for studying the interactions between antiplasmodial antibodies and their immediate target, the free malaria parasites. It allows the combination between in vitro manipulation of free parasites and a subsequent assessment of infectivity in vivo. To our knowledge, no such system has yet been reported in the context of malaria parasites. A similar preparation of free parasites was recently used for a cytochemical study of the parasite's surface (21) . Combined cytochemical immunological manipulations of free parasites may provide information about the molecular nature of the antigens on the surface of the parasites.
